Lipid-related residual risk and renal function for occurrence and prognosis among patients with first-event acute coronary syndrome and normal LDL cholesterol
- PMID: 22099211
- PMCID: PMC3235983
- DOI: 10.1186/1476-511X-10-215
Lipid-related residual risk and renal function for occurrence and prognosis among patients with first-event acute coronary syndrome and normal LDL cholesterol
Abstract
Background: We investigated relationship of low levels of high density lipoprotein cholesterol (HDL-C), high levels of triglycerides, and renal function for the odds, prognosis and survival following acute coronary events among patients with a first event and normal low density lipoprotein cholesterol levels.
Results: A case-control study based on 557 patients and 1086 matched control subjects was conducted. Case patients were followed up for survival with a median of 1.9 years. Participants in the higher quintiles of HDL-C had lower odds to develop acute coronary events (the adjusted odds ratios were 0.24 for the second, 0.24 for the third, 0.10 for the fourth and 0.05 for the fifth quintile). Patients with normal glomerular filtration rate were at a lower risk for all-cause death. However, a reverse association between triglycerides and death risk was found: patients with higher triglycerides were at a lower risk for all-cause death (adjusted relative risk, 0.38 for triglycerides ranging from 82 to 132.9 mg/dL, and 0.14 for triglycerides > = 133 mg/dL).
Conclusions: Low HDL-C was significantly associated with acute coronary events, and triglyceride levels as well as renal function were inversely related to all-cause deaths after the coronary event.
Figures



Similar articles
-
Baseline plasma lipid levels in patients with acute coronary syndrome: Association with 20-year mortality. The ABC-5a* Study on Heart Disease.Int J Clin Pract. 2020 Jun;74(6):e13492. doi: 10.1111/ijcp.13492. Epub 2020 Mar 22. Int J Clin Pract. 2020. PMID: 32083393
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.JAMA. 1998 May 27;279(20):1615-22. doi: 10.1001/jama.279.20.1615. JAMA. 1998. PMID: 9613910 Clinical Trial.
-
Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome.Wien Klin Wochenschr. 2016 Dec;128(23-24):858-863. doi: 10.1007/s00508-016-1035-4. Epub 2016 Jul 5. Wien Klin Wochenschr. 2016. PMID: 27380508
-
Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.Am J Cardiol. 2016 Sep 15;118(6):804-810. doi: 10.1016/j.amjcard.2016.06.048. Epub 2016 Jun 28. Am J Cardiol. 2016. PMID: 27471056
-
Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.Atherosclerosis. 2011 Sep;218(1):163-7. doi: 10.1016/j.atherosclerosis.2011.04.040. Epub 2011 May 6. Atherosclerosis. 2011. PMID: 21605862
Cited by
-
Contemporary Management of Coronary Artery Disease and Acute Coronary Syndrome in Patients with Chronic Kidney Disease and End-Stage Renal Disease.Acta Cardiol Sin. 2013 Mar;29(2):132-41. Acta Cardiol Sin. 2013. PMID: 27122697 Free PMC article. Review.
References
-
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421. - PubMed
-
- Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B. et al.European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007;28(19):2375–2414. - PubMed
-
- Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW. et al.Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115(1):114–126. - PubMed
-
- Standards of medical care in diabetes--2008. Diabetes Care. 2008;31(Suppl 1):S12–54. - PubMed
-
- Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R. et al.Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267–1278. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical